Intracellular glutathione regulates Andrographolide-induced cytotoxicity on hepatoma Hep3B cells

Redox Report

Volumn 14, Issue 4, 2009, Pages 176-184

  Ji, Lili ^a,b   Shen, Kaikai ^a   Liu, Jun ^c   Chen, Ying ^a   Liu, Tianyu ^a   Wang, Zhengtao ^a,b  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b Shanghai R and D Center for Standardization of Chinese Medicines   (China)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Andrographolide; Apoptosis; Glutathione; Hepatoma Hep3B cell

Indexed keywords

ANDROGRAPHOLIDE; BUTHIONINE SULFOXIMINE; DITHIOTHREITOL; GLUTATHIONE; GLUTATHIONE PEROXIDASE; REACTIVE OXYGEN METABOLITE; THIOREDOXIN 1; 6-HYDROXY-2,5,7,8-TETRAMETHYLCHROMAN-2-CARBOXYLIC ACID; ANTIOXIDANT; ASCORBIC ACID; CHROMAN DERIVATIVE; DITERPENE; MANNITOL; TROLOX C;

APOPTOSIS; ARTICLE; CELL LEVEL; CONTROLLED STUDY; DEPLETION; DRUG CYTOTOXICITY; DRUG STRUCTURE; ENZYME ACTIVATION; GLUTATHIONE METABOLISM; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; CELL SURVIVAL; DNA FRAGMENTATION; DRUG EFFECT; METABOLISM; TUMOR CELL LINE; WESTERN BLOTTING;

ANDROGRAPHIS PANICULATA;

ANTIOXIDANTS; APOPTOSIS; ASCORBIC ACID; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL SURVIVAL; CHROMANS; DITERPENES; DITHIOTHREITOL; DNA FRAGMENTATION; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HUMANS; MANNITOL; REACTIVE OXYGEN SPECIES;

EID: 70350452767     PISSN: 13510002     EISSN: 17432928     Source Type: Journal    
DOI: 10.1179/135100009X466122     Document Type: Article

References (33)

1. Fang YZ, Yang S, Wu G. Free radicals, antioxidants and nutrition. Nutrition 2002; 18: 872-879.
2. Lei XG. In vivo antioxidant role of glutathione peroxidase: evidence from knockout mice. Methods Enzymol 2002; 347: 213-215.
3. Griffith OW, Meister A. Glutathione, interorgan translocation, turnover and metabolism. Proc Natl Acad Sci USA 1979; 76: 5606-5610.
4. McCollum AK, TenEyck CJ, Sauer BM, Toft DO, Erlichman CE. Up-regulation of heat shock protein 27 induces resistance to 17- allylamino- demethoxygeldanamycin through a glutathione-mediated mechanism. Cancer Res 2006; 66: 10967-10975.
5. Yue P, Zhou ZM, Khuri FR, Sun SY. Depletion of intracellular glutathione contributions to JNK-mediated death receptor 5 upregulation and apoptosis induction by the novel synthetic triterpenoid methyl-2-cyano-3,12-dioxooleana-1, 9-dien-28-oate (CDDO-Me). Cancer Biol Ther 2006; 5: 492-497.
6. Gonzalez-Santiago L, Suarez Y, Zarich N, et al. Aplidin induces JNK-dependent apoptosis in human breast cancer cells via alteration of glutathione homeostasis, Rac1 GTPase activation, and MKP-1 phosphatase downregulation. Cell Death Difer 2006; 13: 1968-1981.
7. Poolsup N, Suthisisang C, Prathanturarug S, Asawamekin A, Chanchareon U. Andrographis paniculata in the symptomatic treatment of uncomplicated upper respiratory tract infection: systematic review of randomized controlled trials. J Clin Pharm Ther 2004; 29: 37-45.
8. Zhou J, Lu GD, Ong CS, Ong CN, Shen HM. Andrographolide sensitizes cancer cells to TRAIL-induced apoptosis via p53- mediated death receptor 4 up-regulation. Mol Cancer Ther 2008; 7: 2170-2180.
9. Liang FP, Lin CH, Kuo CD, Chao HP, Fu SL. Suppression of v-Src transformation by andrographolide via degradation of the v-Src protein and attenuation of the Erk signaling pathway. J Biol Chem 2008; 283: 5023-5033.
10. Zhou J, Zhang S, Ong CN, Shen HM. Critical role of pro-apoptotic Bcl-2 family members in andrographolide-induced apoptosis in human cancer cells. Biochem Pharmacol 2006; 72: 132-144.
11. Parkin DM. The global burden of cancer. Semin Cancer Biol 1998; 8: 219-235.
12. Thomas MD, O'Beirne JP, Furuse JJ, Chan ATC, Abou-Alfa G, Johnson P. Systemic therapy for hepatocellular carcinoma: cytotoxic chemotherapy, targeted therapy and immunotherapy. Ann Surg Oncol 2008; 15: 1008-1014.
13. Ji LL, Liu TY, Liu J, Chen Y, Wang ZT. Andrographolide inhibits human hepatoma-derived Hep3B cells growth through the activation of c-Jun N-terminal kinase. Planta Med 2007; 73: 1397-1401.
14. Hansen MB, Nielsen SE, Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 1989; 119: 203-210.
15. Sies H, Akerboom TP. Glutathione disulfide (GSSG) efflux from cells and tissues. Methods Enzymol 1984; 105: 445-451.
16. Woo AY, Waye MM, Tsui SK, Yeung ST, Cheng CH. Andrographolide up-regulates cellular-reduced glutathione level and protects cardiomyocytes against hypoxia/reoxygenation injury. J Pharmacol Exp Ther 2008; 325: 226-235.
17. Zhang YG, Mattjus P, Schmid PC et al. Involvement of the acid sphingomyelinase pathway in UVA-induced apoptosis. J Biol Chem 2001; 276: 11775-11782.
18. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG. Selenium: biochemical role as a component of glutathione peroxidase. Science 1973; 179: 588-590.
19. Mathew J, Galarneau L, Loranger A, Gilbert S, Marceau N. Keratin-protein kinase C interaction in reactive oxygen speciesinduced hepatic cell death through mitochondrial signaling. Free Radic Biol Med 2008; 45: 413-424.
20. Griffith OW. Mechanism of actin, metabolism and toxicity of buthionine sulfoximine and its higher homologs, potent inhibitors of glutathione synthesis. J Biol Chem 1982; 257: 13704-13712.
21. Deleve LD, Kaplowitz N. Glutathione metabolism and its role in hepatotoxicity. Pharmacol Ther 1991; 52: 287-305.
22. Zhang ZQ, Chan GK, Li JL, Fong WF, Cheung HY. Molecular interaction between andrographolide and glutathione follows second order kinetics. Chem Pharm Bull 2008, 56: 1229-1233.
23. Zhang K, Chew M, Yang EB, Wong KP, Mack P. Modulation of cisplatin cytotoxicity and cisplatin-induced DNA cross-links in HepG2 cells by regulation of glutathione-related mechanisms. Mol Pharmacol 2001; 59: 837-843.
24. Wang YM, Peng SQ, Zhou Q, et al. Depletion of intracellular glutathione mediates butenolide-induced cytotoxicity in HepG2 cells. Toxicol Lett 2006; 164: 231-238.
25. Chen T, Pearce LL, Peterson J, Stoyanovsky D, Billiar TR. Glutathione depletion renders rat hepatocytes sensitive to nitric oxide donor-mediated toxicity. Hepatology 2005; 42: 598-607.
26. Paul MK, Kumar R, Mukhopadhyay AK. Dithiothreitol abrogates the effect of arsenic trioxide on normal rat liver mitochondria and human hepatocellular carcinoma cells. Toxicol Appl Pharmacol 2008; 226: 140-152.
27. Kelly GS. Clinical application of N-acetylcysteine. Altern Med Rev 1998; 3: 114-127.
28. Watson WH, Yang XM, Choi YE, Jones DP, Kehrer JP. Thioredoxin and it role in toxicology. Toxicol Sci 2004; 78: 3-14.
29. Biaglow JE, Miller RA. The thioredoxin reductase/thioredoxin system. Novel redox targets for cancer therapy. Cancer Biol Ther 2005; 4: 6-13.
30. Lu J, Chew EH, Holmgren A. Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide. Proc Natl Acad Sci USA 2007; 104: 12288-12293
31. Arthur JR. The glutathione peroxidase. Cell Mol Life Sci 2000; 57: 1825-1835.
32. Sies H, Sharov VS, Klotz LO, Briviba K. Glutathione peroxidase protects against peroxynitrite-mediated oxidations. A new function for selenoproteins as peroxynitrite reductase. J Biol Chem 1997; 272: 27812-27817.
33. Li J, Cheung HY, Zhang Z, Chan GK, Fong WF. Andrographolide induces cell cycle arrest at G2/M phase and cell death in HepG2 cells via alteration of reactive oxygen species. Eur J Pharmacol 2007; 568: 31-44.